Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2020-04-08 | 2020-03-31 |
| Drug Identification Number | 01977563 | 01977563 |
| Brand name | TRIAMCINOLONE ACETONIDE SUSPENSION | TRIAMCINOLONE ACETONIDE SUSPENSION |
| Common or Proper name | TRIAMCINOLONE ACETONIDE SUSPENSION | TRIAMCINOLONE ACETONIDE SUSPENSION |
| Company Name | STERIMAX INC | STERIMAX INC |
| Ingredients | TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE |
| Strength(s) | 40MG | 40MG |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | INTRA-ARTICULAR INTRAMUSCULAR | INTRA-ARTICULAR INTRAMUSCULAR |
| Packaging size | 1 VIAL 200 MG / 5 ML | 1 VIAL 200 MG / 5 ML |
| ATC code | H02AB | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2020-03-09 | 2020-03-09 |
| Estimated end date | Unknown | Unknown |
| Actual end date | 2020-04-07 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Product is available at McKesson at 50% allocation. | |
| Health Canada comments |